Watch ULBI. Know when insiders buy.
One email the day a filing lands. Free.
ULBI
ULTRALIFE CORP
6.78
+0.32 +4.95%
USD · close Oct 1
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
9
FLAG · shorts 9
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $113MP/E —DIV YIELD —FCF YIELD 1.80%REV TTM $187.2M +4.7%NET INCOME −$6.5M −304.9%NET DEBT $45.7M52W 5.05 – 7.95SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $47.9M | −1.3% | 28.9% | $3.4M | $2.5M | +189.3% | 15.00 | $1.2M | $453K | $735K | Aug 7 |
| Q1 2026 · Mar 31 | $47.4M | −6.5% | 21.3% | −$215K | −$451K | −124.2% | -3.00 | $2.3M | $770K | $1.5M | May 8 |
| Q4 2025 · Dec 31derived | $48.5M | +10.6% | 24.9% | −$10.6M | −$7.4M | −3925.8% | -35.09 | $1.5M | $882K | $607K | Mar 23 |
| Q3 2025 · Sep 30 | $43.4M | +21.5% | 22.2% | −$951K | −$1.2M | −572.9% | -0.07 | $198K | $995K | −$797K | Nov 17 |
| Q2 2025 · Jun 30 | $48.6M | +13.0% | 23.9% | $2.3M | $879K | −70.4% | 5.00 | $5.9M | $1.1M | $4.8M | Aug 7 |
| Q1 2025 · Mar 31 | $50.7M | +21.0% | 25.1% | $3.4M | $1.9M | −35.5% | 11.00 | $3.4M | $895K | $2.5M | May 8 |
| Q4 2024 · Dec 31derived | $43.9M | −1.6% | 24.2% | $1.5M | $194K | −93.2% | 37.63 | $3M | $606K | $2.4M | Mar 23 |
| Q3 2024 · Sep 30 | $35.7M | −9.6% | 24.3% | $511K | $258K | −80.6% | 0.02 | $4.7M | $594K | $4.2M | Nov 17 |
| Q2 2024 · Jun 30 | $43M | — | 26.9% | $3.9M | $3M | — | 0.18 | $8.9M | $360K | $8.6M | Aug 7 |
| Q1 2024 · Mar 31 | $41.9M | — | 27.4% | $4.1M | $2.9M | — | 0.08 | −$81K | $372K | −$453K | May 12 |
| Q4 2023 · Dec 31derived | $44.5M | — | 25.6% | $3.6M | $2.9M | — | 0.17 | $2.4M | $1M | $1.4M | Apr 1 |
| Q3 2023 · Sep 30 | $39.5M | — | 24.8% | $2.1M | $1.3M | — | 0.08 | −$889K | $534K | −$1.4M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $191.2M | 24.1% | −$5.9M | −$5.9M | -3.1% | -35.00 | $11M | $3.9M | $7.1M | — | — |
| FY2024 · to Dec 31 | $164.5M | 25.7% | $10M | $6.3M | 3.8% | 38.00 | $16.6M | $1.9M | $14.7M | — | — |
| FY2023 · to Dec 31 | $158.6M | 24.7% | $9.5M | $7.2M | 4.5% | 0.44 | $1.9M | $2.6M | −$623K | — | — |
| FY2022 · to Dec 31 | $131.8M | 22.3% | $129K | −$119K | -0.1% | 0.05 | −$1.3M | $1.7M | −$2.9M | — | — |
| FY2021 · to Dec 31 | $98.3M | 25.1% | $35K | −$234K | -0.2% | 0.05 | $4.3M | $2.8M | $1.5M | — | — |
| FY2020 · to Dec 31 | $107.7M | 27.1% | $5.7M | $5.2M | 4.9% | 0.33 | $21.7M | $3.1M | $18.6M | $0 | — |
Every number comes from ULTRALIFE CORP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.